Beta Bionics director awarded 3,997 RSUs

Q: What insider transaction did Beta Bionics (BBNX) report in this Form 4?

The Form 4 reports that director Christy Jones acquired 3,997 shares of Beta Bionics common stock on January 13, 2026 as an equity award, coded as transaction type "A".

Q: Who is Christy Jones in relation to Beta Bionics (BBNX)?

Christy Jones is listed as a Director of Beta Bionics, Inc. on the Form 4, with the director box checked and no officer or 10% owner role indicated.

Q: How many shares were granted to Christy Jones and at what price?

Christy Jones received 3,997 shares of common stock, shown at a transaction price of $0 per share, reflecting a stock-based award rather than a cash purchase.

Q: What plan was the restricted stock unit award for Beta Bionics granted under?

The footnote states the transaction represents a restricted stock unit award granted under Beta Bionics’ 2025 Equity Incentive Plan.

Q: Is Christy Jones’ ownership in Beta Bionics direct or indirect in this filing?

The Form 4 marks the ownership form as Direct (D), and no nature of indirect beneficial ownership is listed, indicating direct ownership of the reported shares.

Beta Bionics, Inc. director Christy Jones reported an equity award on a Form 4.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Beta Bionics, Inc. director Christy Jones reported an equity award on a Form 4. On January 13, 2026, Jones acquired 3,997 shares of common stock with a transaction code "A," indicating an award rather than an open-market purchase, at a stated price of $0 per share.

The footnote explains this represents a restricted stock unit award granted under the company’s 2025 Equity Incentive Plan. Following this grant, Jones beneficially owns 15,244 shares of Beta Bionics common stock in direct ownership.

Insider Trade Summary

Grant/Award: 3,997 shares

Grant/Award 1 txn

Insider Jones Christy

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,997	$0.00	$0.00

Holdings After Transaction: Common Stock — 15,244 shares (Direct)

Footnotes (1)

F1. Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Beta Bionics (BBNX) report in this Form 4?

The Form 4 reports that director Christy Jones acquired 3,997 shares of Beta Bionics common stock on January 13, 2026 as an equity award, coded as transaction type "A".

Who is Christy Jones in relation to Beta Bionics (BBNX)?

Christy Jones is listed as a Director of Beta Bionics, Inc. on the Form 4, with the director box checked and no officer or 10% owner role indicated.

How many shares were granted to Christy Jones and at what price?

Christy Jones received 3,997 shares of common stock, shown at a transaction price of $0 per share, reflecting a stock-based award rather than a cash purchase.

What plan was the restricted stock unit award for Beta Bionics granted under?

The footnote states the transaction represents a restricted stock unit award granted under Beta Bionics’ 2025 Equity Incentive Plan.

How many Beta Bionics shares does Christy Jones own after the reported transaction?

After the reported award, Christy Jones is shown as beneficially owning 15,244 shares of Beta Bionics common stock in direct ownership.

Is Christy Jones’ ownership in Beta Bionics direct or indirect in this filing?

The Form 4 marks the ownership form as Direct (D), and no nature of indirect beneficial ownership is listed, indicating direct ownership of the reported shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 01/14/2026 - 08:30 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jones Christy

(Last)

(First)

(Middle)

C/O BETA BIONICS, INC.

11 HUGHES

(Street)

IRVINE

92618

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Beta Bionics, Inc. [ BBNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	01/13/2026		A		3,997⁽¹⁾	A	$0	15,244	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.

	/s/ Stephen Feider, Attorney-in-Fact	01/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR